Target intelligence / Profile preview

NTM antisense RNA 4 (NTM-AS4)

Target
NTM-AS4
Molecular classification
Long non-coding RNA (lncRNA), Natural antisense transcript (NAT), Non-coding RNA (ncRNA)
01

Overview

NTM antisense RNA 4 (NTM-AS4) is a putative natural antisense transcript (NAT) that is complementary to the sense (mRNA) transcript of the NTM gene. Antisense RNAs such as NTM-AS4 are regulatory non-coding RNAs that can modulate gene expression at transcriptional or post-transcriptional levels, including mechanisms like transcriptional interference, RNA masking, or influencing alternative splicing. NATs have emerging roles in development, disease (notably in cancer through epigenetic regulation), and are being explored as potential therapeutic or biomarker targets. However, there is currently no evidence that NTM-AS4 is a characterized therapeutic target or the focus of drug development, and its biological or clinical functions remain speculative or poorly defined. If you have a specific database reference or context indicating that "NTM antisense RNA 4" refers to a defined and characterized molecule, please clarify for a more precise mapping. Otherwise, this entry is too vague or non-standard to be considered a canonical drug target.

Other names
NTM-AS4NTM natural antisense transcript 4NAT of NTM geneAntisense RNA to NTM
02

Mechanism of action

General for ASOs: RNase H-mediated RNA degradation when targeting NATs; Transcriptional or post-transcriptional regulation via RNA-RNA duplex formation, RNA masking, or interference with splicing

03

Biological functions

Regulation of gene expressionEpigenetic regulationRNA interference/RNA maskingPotential involvement in alternative splicing
04

Disease associations

CancerOther
05

Safety considerations

None known; for the NAT class, challenges include specificity, delivery, and unintended gene silencing effects

Beyond the preview

Go deeper on NTM antisense RNA 4 (NTM-AS4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on NTM antisense RNA 4 (NTM-AS4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call